Characteristics of insulin resistance and insulin secretory capacity in Korean subjects with IFG and IGT

Diabetes Research and Clinical Practice

Volumn 89, Issue 3, 2010, Pages 250-255

  Rhee, Sang Youl ^a,b   Woo, Jeong taek ^b,c   Chon, Suk ^b,c   Hwang, You Cheol ^b,c   Oh, Seungjoon ^b,c   Ahn, Kyu Jeung ^b,c   Chung, Ho Yeon ^b,c   Kim, Sung Woon ^b,c   Kim, Jin Woo ^b,c   Kim, Young Seol ^b,c  

^a Department of Thoracic Surgery Armed Forces Capital Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

Blood glucose; Diabetes mellitus; Hyperglycemia; Insulin resistance; Korea; Prediabetic state; Type 2

Indexed keywords

INSULIN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; ASIAN; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; SOUTH KOREA;

EID: 77955426744     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.05.002     Document Type: Article

References (23)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27(Suppl. 1):S5-S10.
2. Unwin N., Shaw J., Zimmet P., Alberti K.G. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002, 19:708-723.
3. Rosenzweig J.L., Ferrannini E., Grundy S.M., Haffner S.M., Heine R.J., Horton E.S., et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93:3671-3689.
4. Pickup J.C., Williams G. Textbook of diabetes 2003, Blackwell Science, Malden, MA, p. 2.1-2.13. 3rd ed.
5. DECODE Study Group Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998, 317:371-375. (Clinical Research).
6. Qiao Q., Nakagami T., Tuomilehto J., Borch-Johnsen K., Balkau B., Iwamoto Y., et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000, 43:1470-1475.
7. Shaw J.E., Hodge A.M., de Courten M., Chitson P., Zimmet P.Z. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999, 42:1050-1054.
8. Gabir M.M., Hanson R.L., Dabelea D., Imperatore G., Roumain J., Bennett P.H., et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000, 23:1108-1112.
9. Li C, Ford ES, Zhao G, Mokdad AH. Prevalence of Prediabetes and Its Association with Clustering of Cardiometabolic Risk Factors and Hyperinsulinemia Among U.S. Adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care 2008.
10. Abdul-Ghani M.A., Jenkinson C.P., Richardson D.K., Tripathy D., DeFronzo R.A. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006, 55:1430-1435.
11. Perreault L., Bergman B.C., Playdon M.C., Dalla Man C., Cobelli C., Eckel R.H. Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?. Am J Physiol 2008, 295:E428-E435.
12. Kim S.H., Reaven G.M. Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship. Diabetes Care 2008, 31:347-352.
13. American Diabetes Association Standards of medical care in diabetes-2008. Diabetes Care 2008, 31(Suppl. 1):S12-S54.
14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
15. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
16. Rhee S.Y., Chon S., Oh S., Kim S.W., Kim J.W., Kim Y.S., et al. Insulin secretion and insulin resistance in newly diagnosed, drug naive prediabetes and type 2 diabetes patients with/without metabolic syndrome. Diabetes Res Clin Pract 2007, 76:397-403.
17. Faerch K., Vaag A., Holst J.J., Hansen T., Jorgensen T., Borch-Johnsen K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 2009, 32:439-444.
18. Diamond J. The double puzzle of diabetes. Nature 2003, 423:599-602.
19. Chan J.C., Malik V., Jia W., Kadowaki T., Yajnik C.S., Yoon K.H., et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009, 301:2129-2140.
20. Yoon K.H., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006, 368:1681-1688.
21. Abdul-Ghani M.A., Sabbah M., Kher J., Minuchin O., Vardi P., Raz I. Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT. Diabetes Metab Res Rev 2006, 22:126-130.
22. van Genugten R.E., Utzschneider K.M., Tong J., Gerchman F., Zraika S., Udayasankar J., et al. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes 2006, 55:3529-3535.
23. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008, 359:2220-2232.